INFLUENZA A VIRUS IGG ANTIBODY

The INFLUENZA A VIRUS IGG ANTIBODY test detects IgG class antibodies specific to Influenza A in a patient’s blood, indicating prior infection or an immune response following vaccination. The assay is performed on a venous serum sample using validated serological methods (eg, ELISA or chemiluminescence) and reports qualitative (reactive/non‑reactive) and, where available, quantitative titre results. This test is important for assessing past exposure and immune status but is not suitable for diagnosing an acute, active influenza infection.

It is useful for individuals who experienced past flu‑like symptoms, for evaluating vaccine-induced immunity, and for occupational or public-health screening during or after outbreaks — all available with convenient at‑home collection across Dubai by trained phlebotomists. IgG antibodies typically become detectable about 7–14 days after infection or vaccination and may persist for weeks to months; results should be interpreted by a clinician because recent vaccination, cross‑reactivity between strains, or immunosuppression can affect findings.

• Influenza A Virus IgG Antibody
• IgG Antibody Titre (quantitative)
• Result Interpretation (Reactive / Non‑reactive)

• 2–4 weeks after suspected Influenza A infection to confirm past exposure
• 2–6 weeks after influenza vaccination to evaluate immune response
• Following an outbreak for retrospective surveillance or contact tracing
• When clinicians require serological evidence of prior infection
• For occupational or institutional screening where prior immunity is relevant

• Confirms past Influenza A exposure or vaccine-induced antibodies
• Quantitative and qualitative results to support clinical decisions
• Convenient at‑home sample collection across Dubai and UAE
• Lab-based testing using validated methods for reliable results
• Supports public-health surveillance and occupational health assessments

• Venous blood sample collected at home by a certified phlebotomist
• No fasting required prior to sample collection
• Inform the collector if you recently received influenza vaccination or are on immunosuppressive therapy
• Parental consent required for minors; testing available for adults and children